All Stories

  1. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  2. Anticancer Drug Development, Pharmaceutical Progress
  3. Type 2 Diabetes Treatments in Countries of Different Economic Status
  4. Human suicide, biomedical knowledge and therapeutic advances
  5. COVID-19 Research, Public Health and Biomedical Basis
  6. Human Suicide, Management Landscape
  7. Anticancer Drug Development: Evaluative Architecture
  8. COVID-19 Study: A New Principle Discovery
  9. COVID-19 Study, Diagnostic and Therapeutic Transition
  10. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  11. Bone Metastasis Diagnosis, Blood Biomarker Detections
  12. Anti-metastatic drug development, overview and perspectives
  13. Educational Perspectives for Nursery
  14. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  15. Pulmonary nodules, is there any pathogenesis evidence?
  16. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  17. Pulmonary nodules, surgery or other medication
  18. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  19. Pulmonary Nodules, Surgery or Other Medication
  20. Anti-Metastatic Drug Developments, Utility of More Animal Models
  21. Several approaches for anticancer drug development progress
  22. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  23. COVID-19 infection for metabolic abnormal human beings
  24. Fundamental knowledge for nurses 
  25. Nursery promotion, education and system updating
  26. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  27. Cancer Bone Metastasis, Experimental Study
  28. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  29. Osteoporosis Targeting, Possible Breakthroughs
  30. Neuropsychiatric insights for human suicide
  31. Bone Cancer and Metastasis Trials, Drug Treatment
  32. Neurobiology for human suicide
  33. Bone Disease Treatment Study, Major Pathways
  34. Pathology Study for Human Suicide
  35. Nursery activity and quality, chemistry between doctors and nurses
  36. Nursery education, narrow-range or wide-range
  37. Anticancer drug development, challenge and dilemma
  38. Life Origin on Earth, Knowledge Development
  39. HIV/AIDS treatment, therapeutic strategy break throughs
  40. Suicide Risks and Prevention, Neuropathogenic Study
  41. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  42. General information for nursery
  43. Historical analysis of suicide
  44. Drug sensitivity testing, a unique drug selection strategy
  45. Life Origin on Earth, Biochemical Approaches
  46. Herbal medicine in new era
  47. Nursery service, quality promotion
  48. Patient’s care and nursery in different diseases
  49. New HIV/AIDS Therapeutics
  50. Nursery Service in Modern Days
  51. Cancer Bioinformatics in Cancer Therapy
  52. Individualized Cancer Therapy
  53. Type 2 Diabetes Treatment and Drug Development Study
  54. Hypotheses for Life Origin on Earth, Comparison and Validation
  55. Type 2 Diabetes Study, Introduction and Perspective
  56. Anthocyanins and its biological & therapeutic characters
  57. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  58. Pathology and treatments of obesity
  59. Obesity, Risks and Managements
  60. Keep up the pace of drug development evolution and expenditure
  61. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  62. Drug Combination in Clinical Cancer Treatments
  63. General outlook for individualized cancer therapy
  64. Ebola origin and treatment
  65. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  66. HAART in HIV/AIDS Treatments
  67. Anticancer Drug Development, System Updating and Global Participations
  68. Life Origin on Earth, What is the Right Answer?
  69. Human suicide study, major disciplines and treatment outcomes
  70. Anticancer drug development
  71. HIV in Human Genomes and Therapeutics
  72. HIV Biotherapy and Natural Chemotherapeutic Agents
  73. Anticancer Drug Combinations, How Far We can Go Through?
  74. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  75. Life Origin on Earth, Insights among Different Arguments
  76. Cancer metastasis treatment, a key drawbacks
  77. The suicide treatment, a new model
  78. HIV Vaccine for Prevention and Cure, A Mission Possible
  79. Zika Therapy
  80. HIV vaccine
  81. Discover Natural Chemical Drugs in Modern Medicines
  82. Mathematics in biomedical science
  83. The origin of HIV
  84. Human suicide study
  85. Pharmacogenetics of Cancer Therapy
  86. Anticancer Drug Sensitivity Testing
  87. New Perspectives of HIV/AIDS Therapy Study
  88. Antidepressant treatment study
  89. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  90. Assistant cancer treatments in the clinic
  91. Drug sensitivity testing in clinical cancer treatments
  92. Anticancer drug combination in the clinic
  93. Anticancer drug pharmacogenomics in cancer chemotherapy
  94. Cost-effectiveness for personalized cancer therapy
  95. Conclusion
  96. Introduction
  97. Discussion
  98. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  99. Anti-diabetic treatments
  100. Anticancer Drug Combinational Study
  101. The Origins of HIV
  102. Anti-diabetic treatments, patho-therapeutic relation
  103. Origin of Ebola, hypothesis
  104. Personalized Cancer Therapy: A Perspective
  105. Pharmacogenomics in human suicide prediction and treatments
  106. Cancer metastasis treatment study and drug developments
  107. Challenge for HIV/AIDS therapy
  108. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  109. Drug Combinations in Cancer Treatments
  110. New Insights into Individualized Antimetastatic Therapy
  111. Anticancer drugs on serum sialic acid level in mice bearing LLC
  112. Genetics in Neural Toxicity of Drugs
  113. Avian flu, pathogenesis and therapeutic study
  114. First Genetic Information Replication in Life Origin on Earth
  115. Origins of Life, A New Cooperative Model
  116. Cancer Metastases and Clinical Therapies
  117. Origins of Life, RNA world or alternative RNA world
  118. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  119. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  120. Antimetastatic Therapies according to Metastatic Cascade
  121. Genetics in antidepressant-induced suicide
  122. Pathology of Drug-induced mania & suicide
  123. Influenza treatment
  124. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  125. Individualized cancer chemotherapy
  126. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  127. Genomic study of antidepressant-induced suicide
  128. Aberrant sialylation in tumor cells
  129. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  130. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  131. Neural toxicity of drugs
  132. Anticancer activity and mechanisms of Bisdioxopiperazines
  133. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  134. 14C-probimane in the mice bearing LLC
  135. Unsatisfactory design of human AIDS genome research
  136. Antidepressant in Cancer Treatment
  137. AIDS and human genome studies, from a hypothesis to systematic approaches
  138. Antidepressants in Human suicide
  139. Mathematical model in therapeutic risk prediction
  140. Fibrinogen in neoplasm metastasis
  141. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  142. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  143. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  144. Individualized cancer chemotheray
  145. Anti-proliferative and chromosome segregation by probimane and MST-16
  146. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  147. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  148. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  149. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  150. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  151. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  152. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  153. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  154. Journal of Clinical and Medical Reviews